Brief Information of the Cell Line and Protein
Cell Line ID: CL000351 , Dede
Synonyms
DeDe
DEDE
Category Spontaneously immortalized cell line
Organism
Cricetulus griseus (Chinese hamster)
Cellosaurus ID
CVCL_2886
Protein ID: PT00930 , Somatostatin receptor type 1
Gene Name SSTR1
Organism Homo sapiens, Human
Protein Classification Membrane receptor
Uniprot ID P30872
Table of Molecular Bioactivities Related to the Cell Line and Protein
Cell Line ID: CL000351  Protein ID: PT00930
 
Compound ID Compound Name Compound Formula
CP0050675
(4R,7R,10S,13S,16S,19S,22S,25S,28S,31S,34S,37R)-37-{2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-{[(2S)-1-[(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]propanamido]-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}propanamido]-4-(methylsulfanyl)butanamido]propanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanamido]-4-carboxybutanamido]-5-carbamimidamidopentanamido]hexanamido]propanamido]a
   Show/Hide
C137H207N41O39S3
 1
1
IC50 = 1.9 nM
   TI
   LI
   LO
   TS
CP0852833
(5S)-5-[(4R)-4-(benzoylamino)-3-oxo-3,4,5,10-tetrahydroazepino[3,4-b]indol-2(1H)-yl]-6-(benzylamino)-6-oxohexan-1-aminium trifluoroacetate
   Show/Hide
C34H36F3N5O5
 1
1
IC50 = 27 nM
   TI
   LI
   LO
   TS
CP0907338
(5S)-6-(benzylamino)-5-[(4R)-4-[(4-chlorobenzoyl)amino]-3-oxo-3,4,5,10-tetrahydroazepino[3,4-b]indol-2(1H)-yl]-6-oxohexan-1-aminium trifluoroacetate
   Show/Hide
C34H35ClF3N5O5
 1
1
IC50 = 38 nM
   TI
   LI
   LO
   TS
CP0910410
(5S)-6-(benzylamino)-6-oxo-5-[(4R)-3-oxo-4-[(3-phenylpropanoyl)amino]-3,4,5,10-tetrahydroazepino[3,4-b]indol-2(1H)-yl]hexan-1-aminium trifluoroacetate
   Show/Hide
C36H40F3N5O5
 1
1
IC50 = 54 nM
   TI
   LI
   LO
   TS
CP0851107
(5S)-6-oxo-5-[(4R)-3-oxo-4-[(phenylacetyl)amino]-3,4,5,10-tetrahydroazepino[3,4-b]indol-2(1H)-yl]-6-[(2-phenylethyl)amino]hexan-1-aminium trifluoroacetate
   Show/Hide
C36H40F3N5O5
 1
1
IC50 = 75 nM
   TI
   LI
   LO
   TS
CP0851109
(5S)-6-(benzylamino)-6-oxo-5-[(4R)-3-oxo-4-({[4-(2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidin-1-yl]carbonyl}amino)-3,4,5,10-tetrahydroazepino[3,4-b]indol-2(1H)-yl]hexan-1-aminium trifluoroacetate
   Show/Hide
C40H45F3N8O6
 1
1
IC50 = 76 nM
   TI
   LI
   LO
   TS
CP0894372
(5S)-5-[(4R)-4-{[(1-benzoylpiperidin-4-yl)carbonyl]amino}-3-oxo-3,4,5,10-tetrahydroazepino[3,4-b]indol-2(1H)-yl]-6-(benzylamino)-6-oxohexan-1-aminium trifluoroacetate
   Show/Hide
C40H45F3N6O6
 1
1
IC50 = 89 nM
   TI
   LI
   LO
   TS
CP0907350
(S)-6-amino-N-benzyl-2-((R)-4-(3,3-diphenylpropanamido)-3-oxo-4,5-dihydroazepino[3,4-b]indol-2(1H,3H,10H)-yl)hexanamide 2,2,2-trifluoroacetate
   Show/Hide
C42H44F3N5O5
 1
1
IC50 = 89 nM
   TI
   LI
   LO
   TS
CP0852837
(5S)-5-[(4R)-4-(acetylamino)-3-oxo-3,4,5,10-tetrahydroazepino[3,4-b]indol-2(1H)-yl]-6-oxo-6-[(2-phenylethyl)amino]hexan-1-aminium trifluoroacetate
   Show/Hide
C30H36F3N5O5
 1
1
IC50 = 105 nM
   TI
   LI
   LO
   TS
CP0852838
(5S)-6-oxo-5-[(4R)-3-oxo-4-[(phenylacetyl)amino]-3,4,5,10-tetrahydroazepino[3,4-b]indol-2(1H)-yl]-6-{[(1S)-1-phenylethyl]amino}hexan-1-aminium trifluoroacetate
   Show/Hide
C36H40F3N5O5
 1
1
IC50 = 183 nM
   TI
   LI
   LO
   TS
CP0852832
(S)-6-amino-N-benzyl-2-((R)-3-oxo-4-(2-phenylacetamido)-4,5-dihydroazepino[3,4-b]indol-2(1H,3H,10H)-yl)hexanamide 2,2,2-trifluoroacetate
   Show/Hide
C35H38F3N5O5
 1
1
IC50 = 233 nM
   TI
   LI
   LO
   TS
CP0914902
(5S)-6-(benzylamino)-5-[(4R)-4-[(diphenylacetyl)amino]-3-oxo-3,4,5,10-tetrahydroazepino[3,4-b]indol-2(1H)-yl]-6-oxohexan-1-aminium trifluoroacetate
   Show/Hide
C41H42F3N5O5
 1
1
IC50 = 247 nM
   TI
   LI
   LO
   TS
CP0869974
(5S)-5-[(4R)-4-(acetylamino)-3-oxo-3,4,5,10-tetrahydroazepino[3,4-b]indol-2(1H)-yl]-6-(benzylamino)-6-oxohexan-1-aminium trifluoroacetate
   Show/Hide
C29H34F3N5O5
 1
1
IC50 = 253 nM
   TI
   LI
   LO
   TS
CP0851108
(5S)-6-(benzylamino)-6-oxo-5-((4R)-3-oxo-4-(4-(phenylsulfonyl)piperazine-1-carboxamido)-4,5-dihydroazepino[3,4-b]indol-2(1H,3H,10H)-yl)hexan-1-aminium trifluoroacetate
   Show/Hide
C38H44F3N7O7S
 1
1
IC50 = 372 nM
   TI
   LI
   LO
   TS
CP0880681
(5S)-6-(benzylamino)-5-((4R)-4-(2,3-dihydrospiro[indene-1,4'-piperidine]-1'-ylcarboxamido)-3-oxo-4,5-dihydroazepino[3,4-b]indol-2(1H,3H,10H)-yl)-6-oxohexan-1-aminium trifluoroacetate
   Show/Hide
C41H47F3N6O5
 1
1
IC50 = 379 nM
   TI
   LI
   LO
   TS
CP0891468
(5S)-6-[(1-naphthylmethyl)amino]-6-oxo-5-[(4R)-3-oxo-4-[(phenylacetyl)amino]-3,4,5,10-tetrahydroazepino[3,4-b]indol-2(1H)-yl]hexan-1-aminium trifluoroacetate
   Show/Hide
C39H40F3N5O5
 1
1
IC50 = 387 nM
   TI
   LI
   LO
   TS
CP0880682
(5S)-6-oxo-5-[(4R)-3-oxo-4-[(phenylacetyl)amino]-3,4,5,10-tetrahydroazepino[3,4-b]indol-2(1H)-yl]-6-{[(1R)-1-phenylethyl]amino}hexan-1-aminium trifluoroacetate
   Show/Hide
C36H40F3N5O5
 1
1
IC50 = 630 nM
   TI
   LI
   LO
   TS
CP0852834
(5S)-6-(benzylamino)-5-((4R)-4-(1-(methylsulfonyl)spiro[indoline-3,4'-piperidine]-1'-ylcarboxamido)-3-oxo-4,5-dihydroazepino[3,4-b]indol-2(1H,3H,10H)-yl)-6-oxohexan-1-aminium trifluoroacetate
   Show/Hide
C41H48F3N7O7S
 1
1
IC50 = 837 nM
   TI
   LI
   LO
   TS
CP0891469
(5S)-6-methoxy-6-oxo-5-[(4R)-3-oxo-4-[(phenylacetyl)amino]-3,4,5,10-tetrahydroazepino[3,4-b]indol-2(1H)-yl]hexan-1-aminium trifluoroacetate
   Show/Hide
C29H33F3N4O6
 1
1
IC50 = 962 nM
   TI
   LI
   LO
   TS
CP0852836
(5R)-6-(benzylamino)-6-oxo-5-[(4R)-3-oxo-4-[(phenylacetyl)amino]-3,4,5,10-tetrahydroazepino[3,4-b]indol-2(1H)-yl]hexan-1-aminium trifluoroacetate
   Show/Hide
C35H38F3N5O5
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0894371
(5S)-6-(benzylamino)-5-[(4R)-4-[(1,1'-biphenyl-4-ylcarbonyl)amino]-3-oxo-3,4,5,10-tetrahydroazepino[3,4-b]indol-2(1H)-yl]-6-oxohexan-1-aminium trifluoroacetate
   Show/Hide
C40H40F3N5O5
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS